Protalix BioTherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2009 | — | — | $81.3M |
| FY2010 | $76.1M | $64.7M | $35.9M |
| FY2011 | $77.9M | $51.8M | $27.0M |
| FY2012 | $82.1M | $78.7M | $52.0M |
| FY2013 | $140.3M | $113.3M | $86.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2009 | — | — | $81.3M |
| FY2010 | $76.1M | $64.7M | $35.9M |
| FY2011 | $77.9M | $51.8M | $27.0M |
| FY2012 | $82.1M | $78.7M | $52.0M |
| FY2013 | $140.3M | $113.3M | $86.4M |